These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 20809066)

  • 21. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions.
    Loeffler DA; Connor JR; Juneau PL; Snyder BS; Kanaley L; DeMaggio AJ; Nguyen H; Brickman CM; LeWitt PA
    J Neurochem; 1995 Aug; 65(2):710-24. PubMed ID: 7616227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-brain barrier P-glycoprotein function in neurodegenerative disease.
    Bartels AL
    Curr Pharm Des; 2011; 17(26):2771-7. PubMed ID: 21831040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.
    Lu LN; Qian ZM; Wu KC; Yung WH; Ke Y
    Mol Neurobiol; 2017 Sep; 54(7):5213-5224. PubMed ID: 27578012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of hepcidin and interleukin 6 in Parkinson's disease.
    Kwiatek-Majkusiak J; Geremek M; Koziorowski D; Tomasiuk R; Szlufik S; Friedman A
    Acta Neurobiol Exp (Wars); 2020; 80(3):297-304. PubMed ID: 32990287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain Iron Metabolism Dysfunction in Parkinson's Disease.
    Jiang H; Wang J; Rogers J; Xie J
    Mol Neurobiol; 2017 May; 54(4):3078-3101. PubMed ID: 27039308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.
    Thompson K; Menzies S; Muckenthaler M; Torti FM; Wood T; Torti SV; Hentze MW; Beard J; Connor J
    J Neurosci Res; 2003 Jan; 71(1):46-63. PubMed ID: 12478613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An attempt to elucidate the role of iron and zinc ions in development of Alzheimer's and Parkinson's diseases.
    Wojtunik-Kulesza K; Oniszczuk A; Waksmundzka-Hajnos M
    Biomed Pharmacother; 2019 Mar; 111():1277-1289. PubMed ID: 30841441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
    Reichert CO; de Freitas FA; Sampaio-Silva J; Rokita-Rosa L; Barros PL; Levy D; Bydlowski SP
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
    Altamura S; Muckenthaler MU
    J Alzheimers Dis; 2009; 16(4):879-95. PubMed ID: 19387120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases.
    Dusek P; Roos PM; Litwin T; Schneider SA; Flaten TP; Aaseth J
    J Trace Elem Med Biol; 2015; 31():193-203. PubMed ID: 24954801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy and neurodegeneration.
    Ventruti A; Cuervo AM
    Curr Neurol Neurosci Rep; 2007 Sep; 7(5):443-51. PubMed ID: 17764636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
    Oshiro S; Morioka MS; Kikuchi M
    Adv Pharmacol Sci; 2011; 2011():378278. PubMed ID: 22013437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.
    Peters DG; Connor JR; Meadowcroft MD
    Neurobiol Dis; 2015 Sep; 81():49-65. PubMed ID: 26303889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered brain metabolism of iron as a cause of neurodegenerative diseases?
    Gerlach M; Ben-Shachar D; Riederer P; Youdim MB
    J Neurochem; 1994 Sep; 63(3):793-807. PubMed ID: 7519659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
    Mattson MP
    Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells.
    Crichton RR; Wilmet S; Legssyer R; Ward RJ
    J Inorg Biochem; 2002 Jul; 91(1):9-18. PubMed ID: 12121757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ironing out the Brain.
    Ward RJ; Crichton RR
    Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neuropsychiatry of brain iron.
    Sachdev P
    J Neuropsychiatry Clin Neurosci; 1993; 5(1):18-29. PubMed ID: 8094018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
    Hol EM; van Leeuwen FW; Fischer DF
    Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases.
    Zheng W; Monnot AD
    Pharmacol Ther; 2012 Feb; 133(2):177-88. PubMed ID: 22115751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.